APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-PD-1 MAb

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-PD-1 MAb Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026181 pages

Choose your research edition.

Industry ResearchAnti-PD-1 MAb Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-PD-1 MAb Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Anti-PD-1 MAb Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-PD-1 MAb Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-PD-1 MAb Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Anti-PD-1 MAb market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-PD-1 MAb include Thermo Fisher Scientific, Merck KGaA, Ximbio, Sino Biological, OriGene Technologies, Leinco Technologies, Elabscience and BioVision, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Anti-PD-1 MAb market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-PD-1 MAb and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-PD-1 MAb revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anti-PD-1 MAb market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-PD-1 MAb Segment by Company

Thermo Fisher Scientific

Merck KGaA

Ximbio

Sino Biological

OriGene Technologies

Leinco Technologies

Elabscience

BioVision

Anti-PD-1 MAb Segment by Type

1mg

2.5mg

Others

Anti-PD-1 MAb Segment by Application

Pharmaceutical

Research

Other

Anti-PD-1 MAb Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 MAb market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 MAb and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 MAb.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-PD-1 MAb in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-PD-1 MAb industry.

Chapter 3: Detailed analysis of Anti-PD-1 MAb companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-PD-1 MAbrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-PD-1 MAb Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 1mg Table 3. Key Players of 2.5mg Table 4. Key Players of Others Table 4. Global Anti-PD-1 MAb Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Table 6. Key Players of Research Table 7. Key Players of Other Table 8. Global Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Anti-PD-1 MAb Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Anti-PD-1 MAb Market Share by Region (2021-2026) Table 11. Global Anti-PD-1 MAb Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Anti-PD-1 MAb Market Share by Region (2027-2032) Table 13. Anti-PD-1 MAb Industry Trends Table 14. Anti-PD-1 MAb Industry Drivers Table 15. Anti-PD-1 MAb Industry Opportunities and Challenges Table 16. Anti-PD-1 MAb Industry Restraints Table 17. Global Anti-PD-1 MAb Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Anti-PD-1 MAb Revenue Market Share by Company (2021-2026) Table 19. Global Anti-PD-1 MAb Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Anti-PD-1 MAb Key Company Head Office and Area Served Table 21. Global Anti-PD-1 MAb Company, Product Type & Application Table 22. Global Anti-PD-1 MAb Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Anti-PD-1 MAb by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Anti-PD-1 MAb Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Anti-PD-1 MAb Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Anti-PD-1 MAb Revenue Market Share by Type (2021-2026) Table 29. Global Anti-PD-1 MAb Revenue Market Share by Type (2027-2032) Table 30. Global Anti-PD-1 MAb Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Anti-PD-1 MAb Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Anti-PD-1 MAb Revenue Market Share by Application (2021-2026) Table 34. Global Anti-PD-1 MAb Revenue Market Share by Application (2027-2032) Table 35. Thermo Fisher Scientific Company Information Table 36. Thermo Fisher Scientific Business Overview Table 37. Thermo Fisher Scientific Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio Table 39. Thermo Fisher Scientific Recent Development Table 40. Merck KGaA Company Information Table 41. Merck KGaA Business Overview Table 42. Merck KGaA Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck KGaA Anti-PD-1 MAb Product Portfolio Table 44. Merck KGaA Recent Development Table 45. Ximbio Company Information Table 46. Ximbio Business Overview Table 47. Ximbio Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Ximbio Anti-PD-1 MAb Product Portfolio Table 49. Ximbio Recent Development Table 50. Sino Biological Company Information Table 51. Sino Biological Business Overview Table 52. Sino Biological Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sino Biological Anti-PD-1 MAb Product Portfolio Table 54. Sino Biological Recent Development Table 55. OriGene Technologies Company Information Table 56. OriGene Technologies Business Overview Table 57. OriGene Technologies Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. OriGene Technologies Anti-PD-1 MAb Product Portfolio Table 59. OriGene Technologies Recent Development Table 60. Leinco Technologies Company Information Table 61. Leinco Technologies Business Overview Table 62. Leinco Technologies Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Leinco Technologies Anti-PD-1 MAb Product Portfolio Table 64. Leinco Technologies Recent Development Table 65. Elabscience Company Information Table 66. Elabscience Business Overview Table 67. Elabscience Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Elabscience Anti-PD-1 MAb Product Portfolio Table 69. Elabscience Recent Development Table 70. BioVision Company Information Table 71. BioVision Business Overview Table 72. BioVision Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. BioVision Anti-PD-1 MAb Product Portfolio Table 74. BioVision Recent Development Table 75. North America Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Anti-PD-1 MAb Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Anti-PD-1 MAb Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Anti-PD-1 MAb Market Size by Country (2021-2026) Table 81. North America Anti-PD-1 MAb Market Size by Country (2027-2032) Table 82. Europe Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Anti-PD-1 MAb Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Anti-PD-1 MAb Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Anti-PD-1 MAb Market Size by Country (2021-2026) Table 88. Europe Anti-PD-1 MAb Market Size by Country (2027-2032) Table 89. China Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 90. China Anti-PD-1 MAb Market Size by Type (2027-2032) & (US$ Million) Table 91. China Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 92. China Anti-PD-1 MAb Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Anti-PD-1 MAb Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Anti-PD-1 MAb Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Anti-PD-1 MAb Market Size by Country (2021-2026) Table 99. Asia Anti-PD-1 MAb Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Anti-PD-1 MAb Product Image Figure 2. Global Anti-PD-1 MAb Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Anti-PD-1 MAb Market Share by Type: 2025 VS 2032 Figure 4. 1mg Image Figure 5. 2.5mg Image Figure 6. Others Image Figure 7. Global Anti-PD-1 MAb Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Anti-PD-1 MAb Market Share by Application: 2025 VS 2032 Figure 9. Pharmaceutical Image Figure 10. Research Image Figure 11. Other Image Figure 12. Global Anti-PD-1 MAb Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 14. Global Anti-PD-1 MAb Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Anti-PD-1 MAb Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Anti-PD-1 MAb Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Anti-PD-1 MAb Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Anti-PD-1 MAb Revenue Market Share by Type (2021-2032) Figure 21. Global Anti-PD-1 MAb Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Anti-PD-1 MAb Revenue Market Share by Application (2021-2032) Figure 23. North America Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 24. North America Anti-PD-1 MAb Market Share by Type (2021-2032) Figure 25. North America Anti-PD-1 MAb Market Share by Application (2021-2032) Figure 26. North America Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 27. United States Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 28. Canada Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 30. Europe Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 31. Europe Anti-PD-1 MAb Market Share by Type (2021-2032) Figure 32. Europe Anti-PD-1 MAb Market Share by Application (2021-2032) Figure 33. Europe Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 34. Germany Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 35. France Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 37. Italy Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 38. Russia Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 40. China Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 41. China Anti-PD-1 MAb Market Share by Type (2021-2032) Figure 42. China Anti-PD-1 MAb Market Share by Application (2021-2032) Figure 43. Asia Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 44. Asia Anti-PD-1 MAb Market Share by Type (2021-2032) Figure 45. Asia Anti-PD-1 MAb Market Share by Application (2021-2032) Figure 46. Asia Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 47. Japan Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 51. India Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 52. Australia Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Anti-PD-1 MAb Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Anti-PD-1 MAb Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 57. Brazil Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 62. UAE Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 64. Chile Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 2.5mg
  • Others
Applications
  • Pharmaceutical
  • Research
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Merck KGaA
  • Ximbio
  • Sino Biological
  • OriGene Technologies
  • Leinco Technologies
  • Elabscience
  • BioVision

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Anti-PD-1 MAb Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 1mg
  5. 1.2.3 2.5mg
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Anti-PD-1 MAb Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical
  10. 1.3.3 Research
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Anti-PD-1 MAb Growth Trends by Region
  14. 1.5.1 Global Anti-PD-1 MAb Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Anti-PD-1 MAb Market Size by Region (2021-2026)
  16. 1.5.3 Anti-PD-1 MAb Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Anti-PD-1 MAb Market Dynamics
  1. 2.1 Anti-PD-1 MAb Industry Trends
  2. 2.2 Anti-PD-1 MAb Industry Drivers
  3. 2.3 Anti-PD-1 MAb Industry Opportunities and Challenges
  4. 2.4 Anti-PD-1 MAb Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Anti-PD-1 MAb Revenue by Company (2021-2026)
  2. 3.2 Global Anti-PD-1 MAb Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Anti-PD-1 MAb Key Company Head office and Area Served
  4. 3.4 Global Anti-PD-1 MAb Company, Product Type & Application
  5. 3.5 Global Anti-PD-1 MAb Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Anti-PD-1 MAb Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Anti-PD-1 MAb Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Anti-PD-1 MAb Tier 1, Tier 2, and Tier 3
4 Anti-PD-1 MAb Market by Type
  1. 4.1 Global Anti-PD-1 MAb Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Anti-PD-1 MAb Market Size by Type (2021-2032)
  3. 4.3 Global Anti-PD-1 MAb Market Size Share by Type (2021-2032)
5 Anti-PD-1 MAb Market by Application
  1. 5.1 Global Anti-PD-1 MAb Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-PD-1 MAb Market Size by Application (2021-2032)
  3. 5.3 Global Anti-PD-1 MAb Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck KGaA Anti-PD-1 MAb Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Ximbio
  14. 6.3.1 Ximbio Company Information
  15. 6.3.2 Ximbio Business Overview
  16. 6.3.3 Ximbio Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ximbio Anti-PD-1 MAb Product Portfolio
  18. 6.3.5 Ximbio Recent Developments
  19. 6.4 Sino Biological
  20. 6.4.1 Sino Biological Company Information
  21. 6.4.2 Sino Biological Business Overview
  22. 6.4.3 Sino Biological Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sino Biological Anti-PD-1 MAb Product Portfolio
  24. 6.4.5 Sino Biological Recent Developments
  25. 6.5 OriGene Technologies
  26. 6.5.1 OriGene Technologies Company Information
  27. 6.5.2 OriGene Technologies Business Overview
  28. 6.5.3 OriGene Technologies Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 OriGene Technologies Anti-PD-1 MAb Product Portfolio
  30. 6.5.5 OriGene Technologies Recent Developments
  31. 6.6 Leinco Technologies
  32. 6.6.1 Leinco Technologies Company Information
  33. 6.6.2 Leinco Technologies Business Overview
  34. 6.6.3 Leinco Technologies Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Leinco Technologies Anti-PD-1 MAb Product Portfolio
  36. 6.6.5 Leinco Technologies Recent Developments
  37. 6.7 Elabscience
  38. 6.7.1 Elabscience Company Information
  39. 6.7.2 Elabscience Business Overview
  40. 6.7.3 Elabscience Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Elabscience Anti-PD-1 MAb Product Portfolio
  42. 6.7.5 Elabscience Recent Developments
  43. 6.8 BioVision
  44. 6.8.1 BioVision Company Information
  45. 6.8.2 BioVision Business Overview
  46. 6.8.3 BioVision Anti-PD-1 MAb Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BioVision Anti-PD-1 MAb Product Portfolio
  48. 6.8.5 BioVision Recent Developments
7 North America
  1. 7.1 North America Anti-PD-1 MAb Market Size (2021-2032)
  2. 7.2 North America Anti-PD-1 MAb Market Size by Type
  3. 7.2.1 North America Anti-PD-1 MAb Market Size by Type (2021-2026)
  4. 7.2.2 North America Anti-PD-1 MAb Market Size by Type (2027-2032)
  5. 7.2.3 North America Anti-PD-1 MAb Market Share by Type (2021-2032)
  6. 7.3 North America Anti-PD-1 MAb Market Size by Application
  7. 7.3.1 North America Anti-PD-1 MAb Market Size by Application (2021-2026)
  8. 7.3.2 North America Anti-PD-1 MAb Market Size by Application (2027-2032)
  9. 7.3.3 North America Anti-PD-1 MAb Market Share by Application (2021-2032)
  10. 7.4 North America Anti-PD-1 MAb Market Size by Country
  11. 7.4.1 North America Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Anti-PD-1 MAb Market Size by Country (2021-2026)
  13. 7.4.3 North America Anti-PD-1 MAb Market Size by Country (2027-2032)
  14. 7.4.4 North America Anti-PD-1 MAb Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Anti-PD-1 MAb Market Size (2021-2032)
  2. 8.2 Europe Anti-PD-1 MAb Market Size by Type
  3. 8.2.1 Europe Anti-PD-1 MAb Market Size by Type (2021-2026)
  4. 8.2.2 Europe Anti-PD-1 MAb Market Size by Type (2027-2032)
  5. 8.2.3 Europe Anti-PD-1 MAb Market Share by Type (2021-2032)
  6. 8.3 Europe Anti-PD-1 MAb Market Size by Application
  7. 8.3.1 Europe Anti-PD-1 MAb Market Size by Application (2021-2026)
  8. 8.3.2 Europe Anti-PD-1 MAb Market Size by Application (2027-2032)
  9. 8.3.3 Europe Anti-PD-1 MAb Market Share by Application (2021-2032)
  10. 8.4 Europe Anti-PD-1 MAb Market Size by Country
  11. 8.4.1 Europe Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Anti-PD-1 MAb Market Size by Country (2021-2026)
  13. 8.4.3 Europe Anti-PD-1 MAb Market Size by Country (2027-2032)
  14. 8.4.4 Europe Anti-PD-1 MAb Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Anti-PD-1 MAb Market Size (2021-2032)
  2. 9.2 China Anti-PD-1 MAb Market Size by Type
  3. 9.2.1 China Anti-PD-1 MAb Market Size by Type (2021-2026)
  4. 9.2.2 China Anti-PD-1 MAb Market Size by Type (2027-2032)
  5. 9.2.3 China Anti-PD-1 MAb Market Share by Type (2021-2032)
  6. 9.3 China Anti-PD-1 MAb Market Size by Application
  7. 9.3.1 China Anti-PD-1 MAb Market Size by Application (2021-2026)
  8. 9.3.2 China Anti-PD-1 MAb Market Size by Application (2027-2032)
  9. 9.3.3 China Anti-PD-1 MAb Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Anti-PD-1 MAb Market Size (2021-2032)
  2. 10.2 Asia Anti-PD-1 MAb Market Size by Type
  3. 10.2.1 Asia Anti-PD-1 MAb Market Size by Type (2021-2026)
  4. 10.2.2 Asia Anti-PD-1 MAb Market Size by Type (2027-2032)
  5. 10.2.3 Asia Anti-PD-1 MAb Market Share by Type (2021-2032)
  6. 10.3 Asia Anti-PD-1 MAb Market Size by Application
  7. 10.3.1 Asia Anti-PD-1 MAb Market Size by Application (2021-2026)
  8. 10.3.2 Asia Anti-PD-1 MAb Market Size by Application (2027-2032)
  9. 10.3.3 Asia Anti-PD-1 MAb Market Share by Application (2021-2032)
  10. 10.4 Asia Anti-PD-1 MAb Market Size by Country
  11. 10.4.1 Asia Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Anti-PD-1 MAb Market Size by Country (2021-2026)
  13. 10.4.3 Asia Anti-PD-1 MAb Market Size by Country (2027-2032)
  14. 10.4.4 Asia Anti-PD-1 MAb Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Anti-PD-1 MAb Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Anti-PD-1 MAb Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Anti-PD-1 MAb Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Anti-PD-1 MAb Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Anti-PD-1 MAb Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst